Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Can the use of polypharmacy put patients at increased risk for hospitalization, falls, and all-cause mortality?
Read More »The Impact of Polypharmacy in Elderly Patients with Type 2 Diabetes
Dulaglutide Can Reduce Cognitive Impairment in Patients with T2D
A recent exploratory analysis of the REWIND trial evaluated a potential additive benefit to using a once-weekly GLP-1 RA.
Read More »Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE-TIMI 58 Study
Care of the elderly can be very challenging. Can adding yet another medication actually help?
Read More »The Link Between Obesity and Incidence Of Dementia
Higher incidence of dementia tied to central obesity in English women.
Read More »Glycemic Control May Reduce the Risk of Parkinson’s Disease
A recent population-based cohort study offers more insight into the link between glycemic status and the risk for PD.
Read More »Normalizing Glucose Prevents Cognitive Decline
Type 2 diabetes damages brain regions that govern memory, movement, and visual processing.
Read More »Decreased Risk of Death Tied to the Use of Statins
The use of statins in veterans 75 years or older was associated with an overall reduced risk of morbidity and mortality.
Read More »Elderly Women and the Risk of Breast Cancer When Initiating Certain Insulins
Insulin has changed the game in managing people with diabetes but has the potential to cause unwanted severe adverse effects in women 65 years of age and older.
Read More »Effectiveness of Aspirin as Dementia Prophylaxis in Patients with Type 2 Diabetes
Multiple risk factors put patients with T2DM at a high risk of developing dementia.
Read More »Cognitive Decline: Just Life, or a Preventable Disease?
Cognitive decline is associated with many diseases and medications, but the exact mechanisms are not clearly understood.
Read More »